Free Trial
NYSEAMERICAN:ZOM

Zomedica (ZOM) Stock Price, News & Analysis

Zomedica logo

About Zomedica Stock (NYSEAMERICAN:ZOM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.10
$0.15
52-Week Range
N/A
Volume
790,936 shs
Average Volume
4.72 million shs
Market Capitalization
$95.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive ZOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica and its competitors with MarketBeat's FREE daily newsletter.

ZOM Stock News Headlines

Zomedica Achieves Record Revenue Growth in Q2 2025
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
15 Cheapest Stocks Insiders Are Buying In March
See More Headlines

ZOM Stock Analysis - Frequently Asked Questions

Zomedica Corp. (NYSEAMERICAN:ZOM) issued its quarterly earnings results on Thursday, November, 7th. The company reported ($0.01) EPS for the quarter. The company had revenue of $7 million for the quarter. Zomedica had a negative trailing twelve-month return on equity of 12.47% and a negative net margin of 232.88%.
Read the conference call transcript
.

Shares of ZOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zomedica investors own include Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NIO (NIO), Bakkt (BKKT), Phunware (PHUN) and Inuvo (INUV).

Company Calendar

Last Earnings
11/07/2024
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:ZOM
CIK
1684144
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$34.53 million
Net Margins
-232.88%
Pretax Margin
-232.24%
Return on Equity
-12.47%
Return on Assets
-11.84%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.82
Quick Ratio
10.15

Sales & Book Value

Annual Sales
$25.19 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.24 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
979,950,000
Free Float
938,890,000
Market Cap
$95.35 million
Optionable
Not Optionable
Beta
1.03
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSEAMERICAN:ZOM) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners